Leerink Trims PT on Illumina (ILMN) to $185 Following Negative Q3 Preannouncement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Illumina (ILMN) PT Slashed to $137 at Goldman Sachs
October 6, 2015 9:28 AM EDTGoldman Sachs analyst Isaac Ro reiterated a Neutral rating and slashed his price target on Illumina (NASDAQ: ILMN) to $137.00 (from $230.00) after a negative Q3 preannouncement.
Ro commented, "We maintain our Neutral rating but lower our price target to reflect our lower estimates and target multiple. In essence, we attribute the 3Q miss to a product... More
Canaccord Genuity Reiterates Buy on Illumina (ILMN) Following 3Q15 Preliminary Results
October 6, 2015 8:37 AM EDTCanaccord Genuity reiterated a Buy rating and $250.00 price target on Illumina (NASDAQ: ILMN) following the company's preliminary 3Q15 earnings results. ILMN reported preliminary 3Q15 revenues of ~$550M compared to the Streets $569M, citing weakness in Asia and Europe and desktop sequencers.
Analyst... More
Piper Jaffray Cuts Price target on Illumina (ILMN) Following Preliminary 3Q15 Results
October 6, 2015 8:01 AM EDTPiper Jaffray maintained an Overweight rating on Illumina (NASDAQ: ILMN), and cut the price target to $220.00 (from $230.00), following the announced preliminary 3Q15 results. Illumina issued results with revenue increasing ~14% yoy to $550M, below in-line $569.2M estimates and 3Q15 EPS below the Street's $0.83. Management attributed the miss to a... More
Illumina (ILMN) PT Lowered to $200 at UBS; Says May Be Time to Buy
October 6, 2015 7:44 AM EDTUBS analyst Jonathan Groberg lowered his price target on Illumina (NASDAQ: ILMN) to $200.00 (from $250.00) after the company's negative pre-announcement but maintained a Buy rating.
Groberg noted sequencing consumables and instrument sales for the HiSeq family were strong, although desktop sales (e.g. MiSeq & NextSeq) were softer than expected. Geographically, instrument sales were particularly weak in Europe and Japan. Management blamed much of the miss on poor execution in... More
Mizuho Securities Downgrades Illumina (ILMN) to Neutral
October 6, 2015 6:26 AM EDTMizuho Securities downgraded Illumina (NASDAQ: ILMN) from Buy to Neutral with a price target of $150.00 (from $250.00) following the company's negative 3Q and 4Q pre-announcement, which was driven by desktop weakness.
Analyst Eric Criscuolo commented, "While we saw near-term risks around strong comps,... More
Illumina (ILMN) Prelim. Q3 Revenue Misses Expectations; Guides Q4 Revenue Below Consensus
October 5, 2015 4:07 PM EDTIllumina (NASDAQ: ILMN) announced estimated third quarter revenue of approximately $550 million, a 14% increase compared to $481 million in the third quarter of 2014 and 18% growth on a constant currency basis. This estimate, which is unaudited, is based on management's preliminary financial analysis.
*** The Street sees Q3 revenue of $570 million.
Demand for sequencing consumables and the HiSeq family of instruments remained strong during the quarter, while instrument sales in the desktop family... More
